- DKK86.07bn
- DKK109.23bn
- DKK27.87bn
Europe Research Roundup: British Land, Imperial Brands, Vodafone
Coloplast shares hit 2019 low after CEO steps down, 'weak' Q2
Brief: Coloplast Sees 2024/25 EBIT Margin Before Special Items Of 27-28%
Brief: Coloplast CEO Kristian Villumsen Steps Down
Brief: Coloplast Sees 2024/25 EBIT Margin Before Special Items Of 27-28%
Brief: Coloplast Revised Guidance For FY 2024/25
Europe Research Roundup: Alcon, Delivery Hero, Electrolux
Europe Research Roundup: Alphawave, Buzzi, LEG Immobilien
Europe Research Roundup: Adidas, AXA, Greencore
Top of the Street: Novo, Puma, defence companies
JPM ups Coloplast on fair valuation, balanced earnings
Europe Research Roundup: Aperam, Palfinger, SSAB
RBC ups Coloplast to 'outperform' as margin risks subside
Top of the Street: Dassault Systemes, Coloplast, AB Inbev and BCP
Coloplast rises after in-line Q1, analysts point to positioning
Brief: Coloplast - Outlook FY FY 2024/25 Guidance On Organic Growth Of 8-9% And On EBIT Margin Before Special Items Of Around 28% Unchanged
Brief: Coloplast Q1 Adjusted EBIT DKK 1,912 Million
Earnings Poll: Coloplast A/S first quarter results due on February 4
Berenberg predicts 'another eventful year' for MedTech sector